BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 15634986)

  • 21. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
    Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
    Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
    J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
    Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
    Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
    Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
    Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.
    Maertens J; Verhaegen J; Demuynck H; Brock P; Verhoef G; Vandenberghe P; Van Eldere J; Verbist L; Boogaerts M
    J Clin Microbiol; 1999 Oct; 37(10):3223-8. PubMed ID: 10488181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of serum galactomannan detection for diagnosis of invasive aspergillosis in hematopoietic stem cell transplant recipients].
    Ji Y; Liu DH; Xu LP; Liu KY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):83-6. PubMed ID: 17650666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
    Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
    Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
    Racil Z; Weinbergerova B; Kocmanova I; Muzik J; Kouba M; Drgona L; Masarova L; Guman T; Tothova E; Forsterova K; Haber J; Ziakova B; Bojtarova E; Vydra J; Mudry P; Foralova R; Sejnova D; Mallatova N; Kandrnal V; Cetkovsky P; Mayer J
    Int J Infect Dis; 2013 Feb; 17(2):e101-9. PubMed ID: 23084969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
    Oz Y; Aslan M; Aksit F; Metintas S; Gunduz E
    Mycoses; 2016 Feb; 59(2):86-92. PubMed ID: 26627843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.
    Botterel F; Farrugia C; Ichai P; Costa JM; Saliba F; Bretagne S
    Transpl Infect Dis; 2008 Oct; 10(5):333-8. PubMed ID: 18627580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.
    Scotter JM; Campbell P; Anderson TP; Murdoch DR; Chambers ST; Patton WN
    Pathology; 2005 Jun; 37(3):246-53. PubMed ID: 16175901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation.
    Castagnola E; Furfaro E; Caviglia I; Licciardello M; Faraci M; Fioredda F; Tomà P; Bandettini R; Machetti M; Viscoli C
    Clin Microbiol Infect; 2010 Aug; 16(8):1197-203. PubMed ID: 20156215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
    Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
    Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation.
    Kimura S; Akahoshi Y; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    J Infect; 2015 May; 70(5):520-40. PubMed ID: 25743584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the galactomannan assay for the diagnosis of invasive aspergillosis in patients].
    Wen YT; Zhao BL; Lü PH; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):287-90. PubMed ID: 18846967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients.
    Ku NS; Han SH; Choi JY; Kim SB; Kim HW; Jeong SJ; Kim CO; Song YG; Kim JM
    Scand J Infect Dis; 2012 Aug; 44(8):600-4. PubMed ID: 22385270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
    Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
    Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.